Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
IMPROVED OUTCOMES FOLLOWING THE INTRODUCTION OF SURFACTANT TO AN AUSTRALIAN NEONATAL UNIT
Autore:
BEEBY P; CHAN D; HENDERSONSMART D;
Indirizzi:
KING GEORGE V HOSP MOTHERS & BABIES,DEPT PERINATAL MED,MISSENDEN RD CAMPERDOWN NSW 2050 AUSTRALIA UNIV SYDNEY SYDNEY NSW 2006 AUSTRALIA SINGAPORE GEN HOSP,DEPT NEONATOL SINGAPORE 0316 SINGAPORE
Titolo Testata:
Journal of paediatrics and child health
fascicolo: 3, volume: 32, anno: 1996,
pagine: 257 - 260
SICI:
1034-4810(1996)32:3<257:IOFTIO>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
RESPIRATORY-DISTRESS SYNDROME; HYALINE-MEMBRANE DISEASE; CONTROLLED TRIAL; SYNTHETIC SURFACTANT; BOVINE SURFACTANT; CLINICAL-TRIAL; DOUBLE-BLIND; THERAPY; INFANTS; MORTALITY;
Keywords:
ARTIFICIAL SURFACTANT THERAPY; CHRONIC LUNG DISEASE; HYALINE MEMBRANE DISEASE; NEONATAL DEATH; PNEUMOTHORAX;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
19
Recensione:
Indirizzi per estratti:
Citazione:
P. Beeby et al., "IMPROVED OUTCOMES FOLLOWING THE INTRODUCTION OF SURFACTANT TO AN AUSTRALIAN NEONATAL UNIT", Journal of paediatrics and child health, 32(3), 1996, pp. 257-260

Abstract

Objective: To study the impact of the introduction of artificial surfactant therapy for hyaline membrane disease (HMD) in an Australian neonatal intensive care unit Methodology: Infants <32 weeks gestation admitted between June 1991 and Dec 1993 who received treatment with artificial surfactant were compared with infants admitted during the preceding 30 months who would have been candidates for such treatment. Results: For treated infants with gestations in the range 24-27 weeks, there was a significant reduction in neonatal death (adjusted odds ratio 0.28) and a significant increase in the incidence of chronic lung disease (GLD) (adjusted odds ratio 3.4). With gestations in the range 28-31weeks, there was no significant change in neonatal death or CLD, but there was a significant reduction in incidence of pneumothorax (adjusted odds ratio 0.32). Conclusions: A reduced incidence of pneumothorax and neonatal death following the introduction of artificial surfactanttherapy was readily demonstrable in the Australian setting.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/04/20 alle ore 06:40:48